$132.91 Bn Biobanks Market Size, Share, Trends, Opportunities, and Forecasts, 2020-2024 & 2025-2030

Opportunities in the Global Biobanks Market are driven by the demand for high-quality biospecimens in research, advancements in personalized medicine, and investments in biomedical research. Growth potential is also bolstered by the rise in stem cell banking and regenerative medicine applications.

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Biobanks Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" has been added to ResearchAndMarkets.com's offering.

The Global Biobanks Market, valued at USD 79.34 Billion in 2024, is projected to experience a CAGR of 8.98% to reach USD 132.91 Billion by 2030

Biobanks are organized repositories storing biological materials, such as blood and tissue, along with associated clinical and demographic data, primarily for research purposes.

The global biobanks market growth is fundamentally driven by the increasing prevalence of chronic diseases, significant advancements in personalized medicine, and rising investments in biomedical research and drug discovery initiatives.

Key Market Drivers: The increased demand for high-quality biospecimens in research represents a primary market driver, stemming from the critical need for reliable biological materials in scientific inquiry. The integrity and standardized processing of samples are crucial for producing reproducible research outcomes across diverse disciplines including oncology, neuroscience, and infectious diseases.

This stringent demand compels biobanks to implement rigorous quality control measures and advanced storage protocols. According to a July 2024 arXiv article, "Quantifying the Impact of Biobanks and Cohort Studies", 2,663 unique biobanks were mentioned across 228,761 scientific articles as of October 2023, underscoring their critical role in research dissemination and impact. This extensive utilization demonstrates the sustained reliance of the scientific community on robust biospecimen repositories to advance medical understanding.

Key Market Challenges: The substantial upfront capital expenditure required for establishing and maintaining modern biobanking facilities presents a significant challenging factor. This financial barrier directly impedes the expansion of the global biobanks market by limiting the entry of new organizations and restricting the growth capabilities of smaller existing entities. Establishing a biobank necessitates considerable investment in specialized infrastructure, advanced equipment for sample processing and long-term storage, and ongoing expenditure for stringent regulatory compliance and highly skilled personnel. The cumulative financial commitment for such operations is substantial.

Key Market Trends: The Global Biobanks Market is significantly shaped by the increasing prevalence of cord blood and stem cell banking. This trend is driven by growing awareness of stem cells' therapeutic potential across various medical conditions, including hematological disorders and certain cancers. The World Marrow Donor Association (WMDA) reported a substantial inventory of 760,832 cord blood units as of July 2024, demonstrating the scale of these specialized biobanking efforts. This growth is further supported by an expanding number of medical applications and ongoing research into regenerative medicine.

Report Scope

Key Market Players Profiled:

• Danaher Corporation
• Merck KGaA KgaA
• Becton, Dickinson, and Company
• Avantor, Inc.
• Thermo Fisher Scientific , Inc
• Tecan Trading AG
• QIAGEN N.V.
• Hamilton Company
• ProMedDx, LLC
• ISENET Biobanking S.r.l

By Type:

• Disease Oriented Biobanks
• Population Based Biobanks
• Tissue Biobanks
• Others

By Sample Type:

• Blood Products
• Biological Fluids
• Nucleic Acid
• Cell Lines
• Others

By Application:

• Therapeutics
• Drug Discovery
• Clinical Diagnostics
• Clinical Research

By End User:

• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Clinics
• Others

By Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Key Attributes:

Report Attribute	Details
No. of Pages	184
Forecast Period	2024 - 2030
Estimated Market Value (USD) in 2024	$79.34 Billion
Forecasted Market Value (USD) by 2030	$132.91 Billion
Compound Annual Growth Rate	8.9%
Regions Covered	Global

For more information about this report visit https://www.researchandmarkets.com/r/7ypbly

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Biobanks Market

CONTACT: 
CONTACT: ResearchAndMarkets.com 
         Laura Wood, Senior  Press Manager 
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470 
         For U.S./ CAN Toll Free Call 1-800-526-8630 
         For GMT Office Hours Call +353-1-416-8900